174 related articles for article (PubMed ID: 22530028)
1. Performance of papanicolaou testing and detection of cervical carcinoma in situ in participants of organized cervical cancer screening in South Korea.
Han MA; Choi KS; Lee HY; Jun JK; Jung KW; Kang S; Park EC
PLoS One; 2012; 7(4):e35469. PubMed ID: 22530028
[TBL] [Abstract][Full Text] [Related]
2. Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009-2014.
Shim SH; Kim H; Sohn IS; Hwang HS; Kwon HS; Lee SJ; Lee JY; Kim SN; Lee K; Chang S
J Gynecol Oncol; 2017 Sep; 28(5):e63. PubMed ID: 28657224
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer screening in Korea: report on the National Cancer Screening Programme in 2008.
Mun JY; Han MA; Lee HY; Jun JK; Choi KS; Park EC
Asian Pac J Cancer Prev; 2011; 12(8):1961-4. PubMed ID: 22292633
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study.
Jun JK; Choi KS; Jung KW; Lee HY; Gapstur SM; Park EC; Yoo KY
Int J Cancer; 2009 Jan; 124(1):188-93. PubMed ID: 18785204
[TBL] [Abstract][Full Text] [Related]
5. Sociodemographic gradients in breast and cervical cancer screening in Korea: the Korean National Cancer Screening Survey (KNCSS) 2005-2009.
Park MJ; Park EC; Choi KS; Jun JK; Lee HY
BMC Cancer; 2011 Jun; 11():257. PubMed ID: 21682886
[TBL] [Abstract][Full Text] [Related]
6. Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program.
Bui CN; Hong S; Suh M; Jun JK; Jung KW; Lim MC; Choi KS
J Gynecol Oncol; 2021 Sep; 32(5):e81. PubMed ID: 34378364
[TBL] [Abstract][Full Text] [Related]
7. Trend analysis of process quality indicators for the Korean National Cervical Cancer Screening Program from 2005 to 2013.
Bui CN; Choi E; Suh M; Jun JK; Jung KW; Lim MC; Choi KS
J Gynecol Oncol; 2021 Jan; 32(1):e14. PubMed ID: 33327046
[TBL] [Abstract][Full Text] [Related]
8. Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009.
Oh CM; Jung KW; Won YJ; Shin A; Kong HJ; Jun JK; Park SY
PLoS One; 2013; 8(8):e72012. PubMed ID: 23977194
[TBL] [Abstract][Full Text] [Related]
9. Cervical Screening and Colposcopy Management of Women Age 24 and Under.
Buick C; Jembere N; Wang L; Kupets R
J Obstet Gynaecol Can; 2020 Dec; 42(12):1518-1524. PubMed ID: 32988802
[TBL] [Abstract][Full Text] [Related]
10. Contributions and Limitations of National Cervical Cancer Screening Program in Korea: A Retrospective Observational Study.
Lee JH; Kim H; Choi H; Jeong H; Ko Y; Shim SH; Lee E; Chae SH
Asian Nurs Res (Korean Soc Nurs Sci); 2018 Mar; 12(1):9-16. PubMed ID: 29463482
[TBL] [Abstract][Full Text] [Related]
11. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006.
Tangka FK; O'Hara B; Gardner JG; Turner J; Royalty J; Shaw K; Sabatino S; Hall IJ; Coates RJ
Cancer Causes Control; 2010 Jul; 21(7):1081-90. PubMed ID: 20361353
[TBL] [Abstract][Full Text] [Related]
12. Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005-2020.
Shin HY; Lee YY; Song SY; Park B; Suh M; Choi KS; Jun JK
J Gynecol Oncol; 2022 Jul; 33(4):e39. PubMed ID: 35320888
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
14. Breast and Cervical Cancer Screening Prevalence and Associated Factors among Women in the South African General Population.
Phaswana-Mafuya N; Peltzer K
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1465-1470. PubMed ID: 29936716
[TBL] [Abstract][Full Text] [Related]
15. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening in an urban emergency department.
Hogness CG; Engelstad LP; Linck LM; Schorr KA
Ann Emerg Med; 1992 Aug; 21(8):933-9. PubMed ID: 1497160
[TBL] [Abstract][Full Text] [Related]
17. Cervical Cancer Screening Among Adult Women in China, 2010.
Wang B; He M; Chao A; Engelgau MM; Saraiya M; Wang L; Wang L
Oncologist; 2015 Jun; 20(6):627-34. PubMed ID: 25956407
[TBL] [Abstract][Full Text] [Related]
18. Impact of implementing a nationwide cervical cancer screening program on female population coverage by Pap-tests in Estonia.
Veerus P; Arbyn M; Amati C; Paolo B;
Tumori; 2010; 96(4):524-8. PubMed ID: 20968130
[TBL] [Abstract][Full Text] [Related]
19. Effect of Pap smears on the long-term survival of cervical cancer patients: a nationwide population-based cohort study in Korea.
Luu XQ; Lee K; Jun JK; Suh M; Jung KW; Lim MC; Choi KS
Epidemiol Health; 2022; 44():e2022072. PubMed ID: 36108672
[TBL] [Abstract][Full Text] [Related]
20. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
